Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy. | J Biomed Sci | 2021 | 34158025 | PubTator, text mining | PubMed |
| Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers. | Front Mol Biosci | 2021 | 34150845 | PubTator, text mining | PubMed |
| Upregulated osteoprotegerin expression promotes lung cancer cell invasion by increasing miR-20a expression. | Exp Ther Med | 2021 | 34149892 | PubTator, text mining | PubMed |
| S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma. | Aging (Albany NY) | 2021 | 34148033 | PubTator, text mining | PubMed |
| Serum microRNA-33 levels in pre-diabetic and diabetic patients. | Mol Biol Rep | 2021 | 34146198 | PubTator, text mining | PubMed |
| The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review. | Front Cell Dev Biol | 2021 | 34136491 | PubTator, text mining | PubMed |
| PNMA5 Promotes Bone Metastasis of Non-small-Cell Lung Cancer as a Target of BMP2 Signaling. | Front Cell Dev Biol | 2021 | 34136487 | PubTator, text mining | PubMed |
| MicroRNA-199a-5p aggravates angiotensin II-induced vascular smooth muscle cell senescence by targeting Sirtuin-1 in abdominal aortic aneurysm. | J Cell Mol Med | 2021 | 34132029 | PubTator, text mining | PubMed |
| Protective role of ABCA1 in ischemic preconditioning is mediated by downregulation of miR-33-5p and miR-135-5p. | Sci Rep | 2021 | 34131232 | PubTator, text mining | PubMed |
| MicroRNA-326 attenuates immune escape and prevents metastasis in lung adenocarcinoma by targeting PD-L1 and B7-H3. | Cell Death Discov | 2021 | 34131111 | PubTator, text mining | PubMed |
| Ginsenoside Rb1 Enhances Plaque Stability and Inhibits Adventitial Vasa Vasorum via the Modulation of miR-33 and PEDF. | Front Cardiovasc Med | 2021 | 34124194 | PubTator, text mining | PubMed |
| Pathological Crosstalk Between Oxidized LDL and ER Stress in Human Diseases: A Comprehensive Review. | Front Cell Dev Biol | 2021 | 34124059 | PubTator, text mining | PubMed |
| miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling. | J Neuroinflammation | 2021 | 34118948 | PubTator, text mining | PubMed |
| Interactions between m6A modification and miRNAs in malignant tumors. | Cell Death Dis | 2021 | 34108450 | PubTator, text mining | PubMed |
| Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients. | Ther Adv Med Oncol | 2021 | 34104224 | PubTator, text mining | PubMed |
| MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. | Nat Commun | 2021 | 34103512 | PubTator, text mining | PubMed |
| Improvement of hyperlipidemia by aerobic exercise in mice through a regulatory effect of miR-21a-5p on its target genes. | Sci Rep | 2021 | 34099844 | PubTator, text mining | PubMed |
| MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway. | Biosci Rep | 2021 | 34096570 | PubTator, text mining | PubMed |
| The Roles of Host Noncoding RNAs in Mycobacterium tuberculosis Infection. | Front Immunol | 2021 | 34093557 | PubTator, text mining | PubMed |
| Non-Coding RNAs and Extracellular Vehicles: Their Role in the Pathogenesis of Gestational Diabetes Mellitus. | Front Endocrinol (Lausanne) | 2021 | 34093439 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=41